Skip to main content
. 2024 Jun 26;9(8):939–953. doi: 10.1016/j.jacbts.2024.04.011

Table 2.

Baseline Characteristics in Female Patients With POTS and Control Subjects

Control Subjects
(n = 11)
Patients With POTS
(n = 25)
SMD P Value
Demographics
 Age, y 31 ± 7 31 ± 8 0.11 0.76
 Height, cm 163 ± 4 167 ± 9 0.62 0.10
 Weight, kg 62.0 ± 5.2 67.5 ± 8.7 0.71 0.059
 Body mass index, kg/m2 23.5 ± 2.3 24.3 ± 3.9 0.23 0.53
Medications (held/prescribed)
 Beta-blockers NA 11/17 NA
 Midodrine NA 3/9 NA
 Fludrocortisone NA 0/2 NA
 Ivabradine NA 1/2 NA
 Sympatholytic NA 5/6 NA
 Pyridostigmine NA 1/2 NA
Ventilatory
 Ventilation, L/min 10.1 ± 2.0 9.2 ± 2.6 0.35 0.34
 End-tidal CO2, mm Hg 39.5 ± 2.9 38.0 ± 3.8 0.42 0.26
 End-tidal O2, mm Hg 90.4 ± 5.0 92.5 ± 7.0 0.32 0.39
Peripheral hemodynamics
 Heart rate, beats/min 69 ± 9 71 ± 13 0.13 0.72
 Stroke volume, mL 78 ± 12 79 ± 15 0.05 0.89
 Cardiac output, L/min 5.4 ± 0.7 5.6 ± 1.1 0.18 0.62
 Mean arterial pressure, mm Hg 91 ± 12 91 ± 13 0.01 0.97
 Systemic vascular resistance, dynes/cm5 1,920 ± 695 1,671 ± 557 0.41 0.26
 Pulse pressure, mm Hg 66 ± 9 63 ± 11 0.32 0.38
 Arterial pulsatility index 0.73 ± 0.1 0.69 ± 0.1 0.39 0.29
Cerebral hemodynamics
 MCAvmean, cm/s 85 ± 10 78 ± 13 0.62 0.094
 MCAvpeak, cm/s 123 ± 14 114 ± 18 0.57 0.12
 MCAvmin, cm/s 66 ± 8 60 ± 11 0.63 0.093
 MCAv pulsatility index 0.68 ± 0.1 0.70 ± 0.1 0.26 0.48
Sympathetic (n = 9) (n = 12)
 Burst frequency, bursts/min 15 ± 6 13 ± 5 0.51 0.26
 Burst amplitude, % of peak 40 ± 9 41 ± 14 0.12 0.78
 Total MSNA, AU/min 645 ± 312 566 ± 320 0.25 0.58

Values are mean ± SD. Group differences were compared using an independent-samples 2-tailed Student’s t-test.

AU = arbitrary units; MCAv = middle cerebral artery velocity; MSNA = muscle sympathetic nerve activity; NA = not applicable; POTS = postural orthostatic tachycardia syndrome; SMD = standardized mean difference.